BPMC
Hudson Bay Capital Management’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.6M | Buy |
+129,398
| New | +$16.6M | 0.06% | 168 |
|
2024
Q2 | – | Sell |
-49,800
| Closed | -$4.72M | – | 661 |
|
2024
Q1 | $4.72M | Buy |
49,800
+9,800
| +25% | +$930K | 0.03% | 259 |
|
2023
Q4 | $3.69M | Sell |
40,000
-180,000
| -82% | -$16.6M | 0.02% | 301 |
|
2023
Q3 | $11M | Buy |
220,000
+73,400
| +50% | +$3.69M | 0.09% | 123 |
|
2023
Q2 | $9.27M | Sell |
146,600
-176,400
| -55% | -$11.1M | 0.07% | 149 |
|
2023
Q1 | $14.5M | Buy |
323,000
+109,832
| +52% | +$4.94M | 0.12% | 98 |
|
2022
Q4 | $9.34M | Buy |
213,168
+178,168
| +509% | +$7.81M | 0.1% | 167 |
|
2022
Q3 | $2.31M | Sell |
35,000
-200,900
| -85% | -$13.2M | 0.02% | 666 |
|
2022
Q2 | $11.9M | Buy |
235,900
+170,900
| +263% | +$8.63M | 0.09% | 121 |
|
2022
Q1 | $4.15M | Buy |
+65,000
| New | +$4.15M | 0.06% | 422 |
|
2021
Q4 | – | Sell |
-12,500
| Closed | -$1.29M | – | 1072 |
|
2021
Q3 | $1.29M | Sell |
12,500
-12,500
| -50% | -$1.29M | 0.02% | 682 |
|
2021
Q2 | $2.2M | Buy |
+25,000
| New | +$2.2M | 0.03% | 576 |
|
2020
Q3 | – | Sell |
-60,000
| Closed | -$4.68M | – | 532 |
|
2020
Q2 | $4.68M | Sell |
60,000
-25,000
| -29% | -$1.95M | 0.08% | 198 |
|
2020
Q1 | $4.97M | Buy |
85,000
+30,000
| +55% | +$1.75M | 0.12% | 150 |
|
2019
Q4 | $4.41M | Buy |
+55,000
| New | +$4.41M | 0.1% | 179 |
|
2019
Q2 | – | Sell |
-20,000
| Closed | -$1.6M | – | 390 |
|
2019
Q1 | $1.6M | Sell |
20,000
-45,000
| -69% | -$3.6M | 0.02% | 297 |
|
2018
Q4 | $3.5M | Hold |
65,000
| – | – | 0.05% | 206 |
|
2018
Q3 | $5.07M | Sell |
65,000
-10,000
| -13% | -$781K | 0.06% | 156 |
|
2018
Q2 | $4.76M | Buy |
75,000
+45,000
| +150% | +$2.86M | 0.07% | 154 |
|
2018
Q1 | $2.75M | Hold |
30,000
| – | – | 0.06% | 210 |
|
2017
Q4 | $2.26M | Buy |
+30,000
| New | +$2.26M | 0.05% | 206 |
|